Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
The patient, however, pays cost-sharing calculated against WAC at the point of sale, not against the net price
(PubMed) Nguyen N, Takemoto JK
Levine S., Sowinski R
The study "Liraglutide versus placebo as an adjunct to glucose-lowering therapy in patients with type 2 diabetes and moderate renal failure" (LIRA-RENAL) did not demonstrate a benefit of liraglutide in lowering eGFR, although the duration of the study (26 weeks) may have been insufficient to show an effect
Menu News Needle Little Transparency: Alabama AG Targets Research-Grade GLP-1s Alabama AG Steve Marshall obtained a temporary restraining order against Aurora IV and Wellness, an infusion clinic, and its owners in a case alleging that they administered research-grade weight loss drugs without patients knowledge or consent, in violation of Alabamas Deceptive Trade Practices Act
